Medicines for human purposes; injection (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations); active pharmaceutical ingredients being drugs; Chinese medicines (term considered too vague by the International Bureau - rule 13 (2) (b) of the Regulations); troche; chemico-pharmaceutical preparations; antibiotics; dietetic substances adapted for medical use; nutritional supplements; bandages for dressings.